My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Certara, Inc. - Common Stock (NQ:CERT)

6.460 -0.190 (-2.86%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Forecasting The Future: 4 Analyst Projections For Certara ↗

November 07, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗

October 15, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗

September 27, 2024

Via Benzinga

IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday ↗

September 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 27, 2024

Via Benzinga

CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Decoding 4 Analyst Evaluations For Certara ↗

April 04, 2024

Via Benzinga

Analyst Scoreboard: 4 Ratings For Certara ↗

March 01, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

CERT stock results show that Certara met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies ↗

January 30, 2024

New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop could impact ETFs.

Via Benzinga

Recap: Certara Q3 Earnings ↗

November 08, 2023

Via Benzinga

The Latest Analyst Ratings for Certara ↗

October 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023 ↗

August 22, 2023

Via Benzinga

The Latest Analyst Ratings for Certara ↗

August 11, 2023

Via Benzinga

Looking Into Certara's Return On Capital Employed ↗

May 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 ↗

August 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 10, 2023

Via Benzinga

Analyst Expectations for Certara's Future ↗

April 12, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗

April 12, 2023

Via Benzinga

Expert Ratings for Certara ↗

March 27, 2023

Via Benzinga

Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday ↗

March 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Where Certara Stands With Analysts ↗

March 02, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023 ↗

April 04, 2023

Via Benzinga

Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday ↗

March 02, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Why Certara's Shares Rose 37.7% This Week ↗

November 11, 2022

The company, which helps other companies in their drug development, reported strong third-quarter numbers.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.